Affordable Access

Publisher Website

Measuring flushing symptoms with extended-release niacin using the flushing symptom questionnaire: results from a randomised placebo-controlled clinical trial.

Authors
  • 1
Type
Published Article
Journal
International journal of clinical practice
1742-1241
Publication Date
Volume
62
Issue
6
Pages
896–904
Identifiers
DOI: 10.1111/j.1742-1241.2008.01739.x
PMID: 18410350
Source
Medline

Abstract

In conclusion, the GFSS component of the FSQ was a sensitive and responsive quantitative measure of ER niacin-induced flushing that will aid in the objective comparison of novel strategies intended to improve tolerability and adherence to niacin, an agent proven to reduce cardiovascular risk.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F